Exploiting APC Function As a Novel Cancer Therapy

Total Page:16

File Type:pdf, Size:1020Kb

Exploiting APC Function As a Novel Cancer Therapy Send Orders for Reprints to reprints@benthamscience.net 90 Current Drug Targets, 2014, 15, 90-102 Exploiting APC Function as a Novel Cancer Therapy Alyssa C. Lesko1, Kathleen H. Goss2 and Jenifer R. Prosperi1,3,* 1Department of Biological Sciences, University of Notre Dame, Notre Dame, IN 46556, 2Department of Surgery, University of Chicago, Chicago, IL 60637, 3Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, South Bend, IN 46617, USA Abstract: The Adenomatous Polyposis Coli (APC) tumor suppressor is most commonly mutated in colorectal cancers such as familial adenomatous polyposis (FAP); as well as many other epithelial cancers like breast, pancreatic, and lung cancer. APC mutations usually result in a truncated form of the protein lacking the carboxy-terminal region resulting in loss of function. Mutations in APC have been identified in early stages of cancer development making it a gatekeeper of tumor progression and therefore an ideal therapeutic target. APC is best known for its role as a negative regulator of the Wnt/ -catenin pathway. However, APC also mediates several other normal cell functions independently of Wnt/-catenin signaling such as apical-basal polarity, microtubule networks, cell cycle, DNA replication and repair, apoptosis, and cell migration. Given the vast cellular processes involving APC, the loss of these “normal” functions due to mutation can con- tribute to chemotherapeutic resistance. Several therapeutic treatments have been explored to restore APC function includ- ing the reintroduction of APC into mutant cells, inhibiting pathways activated by the loss of APC, and targeting APC- mutant cells for apoptosis. This review will discuss the normal functions of APC as they relate to potential treatments for patients, the role of APC loss in several types of epithelial cancers, and an overview of therapeutic options targeting both the Wnt-dependent and -independent functions of APC. Keywords: APC, cancer, targeted therapy, tumor suppressor INTRODUCTION of APC as they relate to potential treatments for patients with APC-mutant tumors, will discuss the importance of APC in a Mutations in the Adenomatous Polyposis Coli (APC) tu- variety of epithelial-derived tumors, and finally will investi- mor suppressor gene are most commonly found in colorectal gate options for restoring APC function and therefore treat- cancers such as the inherited syndrome familial adenomatous ing APC-mutant tumors. polyposis (FAP), but have also been identified in many epithelial cancers including breast cancer ([1-3] and re- NORMAL FUNCTIONS OF THE APC TUMOR SUP- viewed in [4]). Most APC mutations are nonsense mutations, PRESSOR frequently created by frame-shifts, resulting in premature stop codons and a truncated gene product lacking the car- APC (by convention, the human and mouse genes are boxy-terminus of the protein. Patients with FAP inherit one APC and Apc, respectively, whereas the protein from all spe- germline mutation and develop tumors when another somatic cies is APC) is a large multifunctional protein made up of mutation is received resulting in loss of the wild-type APC 2843 amino acids and multiple binding domains. While the allele. In this way, APC mutation follows the classical ‘two- best-known role of APC is to act as a negative regulator of hit’ model. The disease presentation in patients with APC the Wnt/-catenin signaling pathway, there are many other mutation often depends on the location of the mutation. For normal functions of APC. Based on the ability of APC to example, mutations at the 5’ and 3’ ends of the coding se- bind a variety of protein partners, other activities of APC quence are associated with a weakened FAP phenotype, include mediating cell migration, regulation of apical-basal while extracolonic phenotypes are associated with mutations polarity, microtubule networks, cell cycle, DNA replication in other regions of the sequence ([5] and reviewed in [6]). and repair, and apoptosis (summarized in Fig. 1). These Importantly, APC mutations similar to those found in FAP functions of APC, including regulation of Wnt/-catenin have been identified in 50-80% of sporadic colon adenomas signaling and other non-Wnt related functions have been and adenocarcinomas (reviewed in [4, 7]). Since APC has recently reviewed elsewhere [9, 10]. Prior to discussion of been identified in the earliest stages of tumor progression targeting APC loss in cancer therapeutics, we will briefly [8], it has emerged as the ‘gatekeeper’ of colorectal cancer summarize some key functions of APC that may be targeted development. This review will describe the normal functions in cancer. Association of APC with Polarity and Junctional Com- *Address correspondence to this author at the Department of Biochemistry plexes and Molecular Biology, Indiana University School of Medicine – South Bend, 1234 Notre Dame Ave, South Bend, IN 46617, USA; Role in Apical-Basal Polarity of Epithelial Cells: Some Tel.: 574-631-4002; Fax: 574-631-8932; Email: jrprospe@iupui.edu non-gastrointestinal model systems have provided evidence 1873-5592/14 $58.00+.00 © 2014 Bentham Science Publishers Exploiting APC Function as a Novel Cancer Therapy Current Drug Targets, 2014, Vol. 15, No. 1 91 Fig. (1). APC protein structure. Specific APC functional domains are shown, and known binding partners are listed below the domain with which they interact. for the involvement of APC in regulating aspects of apical- uted to this function; however, the loss of epithelial polarity basal polarity and epithelial morphogenesis. For example, a and the disruption of tissue organization are normally associ- role for APC in overall epithelial organization is supported ated with more aggressive cancers ([19, 20] for review). by the homozygous germline deletion of Apc preventing de- Moreover, disrupted localization of adherens junction pro- velopment past embryonic day 6 [11]. Apc mutations in the teins is frequent in cancers [21], and components of the mature cochlea result in a decreased number of parallel mi- Scrib/Dlg/Lgl complex, protein partners of APC, have re- crotubule arrays, which are essential for epithelial polariza- cently been implicated in several cancers such as cervical tion [12]. Studies from our laboratory have also demon- and colorectal cancer [20, 22, 23]. Collectively, these data strated a role for APC in mammary epithelial cell polariza- support a role for APC in epithelial polarization that may be tion and morphogenesis as ApcMin/+ female mice, containing important for its function during tumor development. a mutant Apc allele, exhibited altered mammary epithelial Junctional Complexes: A potential role of APC in medi- polarity and overall integrity [13]. In addition, knockdown of ating cell-cell interactions and cell migration emerged APC in the Madin-Darby Canine Kidney (MDCK) model, a through the interaction of APC with -catenin at the adher- standard model for epithelial polarity, resulted in altered ens junction [24], and plakoglobin (-catenin), at the desmo- epithelial morphogenesis and polarity defects in 3D culture some [25, 26]. However, the APC/-catenin and - (J.R.P and K.H.G., submitted). In Drosophila neuroepithelial catenin/E-cadherin complexes were observed to be mutually cells, APC is recruited to the adherens junction, and mediates exclusive [24, 26, 27], and studies have largely focused on symmetric cell division along the planar axis through its in- APC’s regulation of the Wnt pathway through -catenin deg- teractions with microtubules by positioning the mitotic spin- radation. Although the role of APC in cellular adhesion, mo- dle [14]. Other roles for APC include the polarized distribu- tility, polarization, and morphogenesis has been overshad- tion of MUC1, a transmembrane glycoprotein that is fre- owed, there is evidence that unregulated APC levels are as- quently mislocalized in cancers, to the apical membrane of sociated with altered cell migration and adhesion. Manipula- differentiated mammary epithelial cells [13], and the binding tion of APC levels in mouse intestinal epithelial cells re- of APC to Striatin, a calmodulin-binding protein predomi- sulted in altered enterocyte migration along intestinal villi in nately expressed in the central nervous system, in cell-cell vivo [28-30]. Reintroduction of APC in SW480 (APC- junctions [15]. mutant) colorectal cancer cells caused changes in the local- The role of APC in maintaining apical-basal polarity is ization of adherens junction proteins, tighter cell-cell con- also conveyed in it’s importance in epithelial cell differentia- tacts, and an epithelial phenotype [31]. Localization of APC tion, as the establishment of polarity is required for differen- at cell-cell contacts has been shown to be dependent on - tiation. APC’s role in zebrafish intestinal differentiation in- catenin and VE-cadherin, as depletion of either -catenin or volves the transcriptional co-repressor carboxy-terminal VE-cadherin resulted in the disruption of cell-cell adhesion binding protein 1 (CtBP1), which interacts with APC to and the loss of APC from the lateral membrane [32]. Studies drive differentiation independent of -catenin through con- using wound healing assays also showed that the inhibition trolling the expression of enzymes like intestinal retinal de- of glycogen synthase kinase 3 (GSK3) and casein kinase I hydrogenases [16, 17]. A recent study showed that APC is (CK1) decreased wound closure, suggesting that cell mi- also required for apical extrusion of human
Recommended publications
  • Table 2. Significant
    Table 2. Significant (Q < 0.05 and |d | > 0.5) transcripts from the meta-analysis Gene Chr Mb Gene Name Affy ProbeSet cDNA_IDs d HAP/LAP d HAP/LAP d d IS Average d Ztest P values Q-value Symbol ID (study #5) 1 2 STS B2m 2 122 beta-2 microglobulin 1452428_a_at AI848245 1.75334941 4 3.2 4 3.2316485 1.07398E-09 5.69E-08 Man2b1 8 84.4 mannosidase 2, alpha B1 1416340_a_at H4049B01 3.75722111 3.87309653 2.1 1.6 2.84852656 5.32443E-07 1.58E-05 1110032A03Rik 9 50.9 RIKEN cDNA 1110032A03 gene 1417211_a_at H4035E05 4 1.66015788 4 1.7 2.82772795 2.94266E-05 0.000527 NA 9 48.5 --- 1456111_at 3.43701477 1.85785922 4 2 2.8237185 9.97969E-08 3.48E-06 Scn4b 9 45.3 Sodium channel, type IV, beta 1434008_at AI844796 3.79536664 1.63774235 3.3 2.3 2.75319499 1.48057E-08 6.21E-07 polypeptide Gadd45gip1 8 84.1 RIKEN cDNA 2310040G17 gene 1417619_at 4 3.38875643 1.4 2 2.69163229 8.84279E-06 0.0001904 BC056474 15 12.1 Mus musculus cDNA clone 1424117_at H3030A06 3.95752801 2.42838452 1.9 2.2 2.62132809 1.3344E-08 5.66E-07 MGC:67360 IMAGE:6823629, complete cds NA 4 153 guanine nucleotide binding protein, 1454696_at -3.46081884 -4 -1.3 -1.6 -2.6026947 8.58458E-05 0.0012617 beta 1 Gnb1 4 153 guanine nucleotide binding protein, 1417432_a_at H3094D02 -3.13334396 -4 -1.6 -1.7 -2.5946297 1.04542E-05 0.0002202 beta 1 Gadd45gip1 8 84.1 RAD23a homolog (S.
    [Show full text]
  • XP725 Antibody List Lot 129K4830
    Panorama® Antibody Microarray-XPRESS Profiler725, XP725 List of Antibodies Lot: 129K4830 Reactivity Number Antibody Sigma No. Gene Ids Gene Symbols P/M Accessions Human Mouse Rat 3 Actin A5060 58 ACTA1 P NP_001091.1 n/d n/d n/d 5 Actin, αβ-Smooth Muscle A5228 59 ACTA2 M NP_001135417.1, NP_001604.1, yyy 6 β-Actin A1978 60 ACTB M NP_001092.1 yyy 7 β-Actin A2228 60 ACTB M NP_001092.1 yyy 8 a-Actinin A5044 87 ACTN1 M NP_001093.1 y y n/d 555 PARP P7605 142 PARP1 P NP_001609.2 y n/d n/d 11 β1 and β2-Adaptins A4450 162 AP1B1 M NP_001118.3 y n/d y 167 Chondroitin Sulfate C8035 176 ACAN M NP_001126.3, NP_037359.3 yyy 574 Protein Kinase Ba /Akt1 P2482 207 AKT1 M NP_001014431.1,NP_001014432.1 , NP_005154.2, yyy 575 Protein Kinase Ba /Akt1 P1601 207 AKT1 P NP_001014431.1,NP_001014432.1 , NP_005154.2, yyy 577 phospho-PKB (pSer473) P4112 207 AKT1 P NP_001014431.1,NP_001014432.1 , NP_005154.2, n/d y y 578 phospho-PKB (pThr308) P3862 207 AKT1 P NP_001014431.1,NP_001014432.1 , NP_005154.2, n/d y y 22 Annexin V A8604 308 ANXA5 M NP_001145.1 y n/d n/d 23 Annexin VII A4475 310 ANXA7 M NP_001147.1 yyy 29 Apaf1, N-Terminal A8469 317 APAF1 P NP_001151.1 y y n/d 457 Mint2 M3319 321 APBA2 P NP_001123886.1 n/d n/d y 28 AP Endonuclease A2105 328 APEX1 M NP_001632.2,NP_542379.1,NP_542380.1 yyy 692 Survivin S8191 332 BIRC5 P NP_001012270.1 yyy 17 β-Amyloid A8354 351 APP M NP_000475.1,NP_001129488.1 ,NP_001129601.1 ,NP_001129602.1 ,NP_001129603.1 ,NP_001191230.1 ,NP_001191231.1 ,NP_001191232.1,NP_958816.1,NP_9 y n/d n/d 18 Amyloid Precursor Protein, C-Terminal A8717
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Supplemental Information For
    Supplemental Information for: Gene Expression Profiling of Pediatric Acute Myelogenous Leukemia Mary E. Ross, Rami Mahfouz, Mihaela Onciu, Hsi-Che Liu, Xiaodong Zhou, Guangchun Song, Sheila A. Shurtleff, Stanley Pounds, Cheng Cheng, Jing Ma, Raul C. Ribeiro, Jeffrey E. Rubnitz, Kevin Girtman, W. Kent Williams, Susana C. Raimondi, Der-Cherng Liang, Lee-Yung Shih, Ching-Hon Pui & James R. Downing Table of Contents Section I. Patient Datasets Table S1. Diagnostic AML characteristics Table S2. Cytogenetics Summary Table S3. Adult diagnostic AML characteristics Table S4. Additional T-ALL characteristics Section II. Methods Table S5. Summary of filtered probe sets Table S6. MLL-PTD primers Additional Statistical Methods Section III. Genetic Subtype Discriminating Genes Figure S1. Unsupervised Heirarchical clustering Figure S2. Heirarchical clustering with class discriminating genes Table S7. Top 100 probe sets selected by SAM for t(8;21)[AML1-ETO] Table S8. Top 100 probe sets selected by SAM for t(15;17) [PML-RARα] Table S9. Top 63 probe sets selected by SAM for inv(16) [CBFβ-MYH11] Table S10. Top 100 probe sets selected by SAM for MLL chimeric fusion genes Table S11. Top 100 probe sets selected by SAM for FAB-M7 Table S12. Top 100 probe sets selected by SAM for CBF leukemias (whole dataset) Section IV. MLL in combined ALL and AML dataset Table S13. Top 100 probe sets selected by SAM for MLL chimeric fusions irrespective of blast lineage (whole dataset) Table S14. Class discriminating genes for cases with an MLL chimeric fusion gene that show uniform high expression, irrespective of blast lineage Section V.
    [Show full text]
  • Cilium Structure, Assembly, and Disassembly Regulated by the Cytoskeleton
    Biochemical Journal (2018) 475 2329–2353 https://doi.org/10.1042/BCJ20170453 Review Article Cilium structure, assembly, and disassembly regulated by the cytoskeleton Mary Mirvis1,*, Tim Stearns2,3 and W. James Nelson1,2 1Department of Molecular and Cellular Physiology, Stanford University, Stanford, CA 94305, U.S.A.; 2Department of Biology, Stanford University, Stanford, CA 94305, U.S.A.; 3Department of Genetics, Stanford University, Stanford, CA 94305, U.S.A. Correspondence: W. James Nelson (wjnelson@stanford.edu) The cilium, once considered a vestigial structure, is a conserved, microtubule-based organelle critical for transducing extracellular chemical and mechanical signals that control cell polarity, differentiation, and proliferation. The cilium undergoes cycles of assembly and disassembly that are controlled by complex inter-relationships with the cytoskeleton. Microtubules form the core of the cilium, the axoneme, and are regulated by post-translational modifications, associated proteins, and microtubule dynamics. Although actin and septin cytoskeletons are not major components of the axoneme, they also regulate cilium organization and assembly state. Here, we discuss recent advances on how these different cytoskeletal systems affect cilium function, structure, and organization. Introduction Cilia are specialized, conserved organelles that are evolutionarily optimized for interaction with the world outside of the cell. They protrude into the extracellular space, are structurally resilient but also flexible and dynamic, and have unique mechanisms to tightly control their internal and membrane composition. These features ensure that the cilium is primed to perform highly regulated signaling, mechanosensory, and motile functions. In this review, we consider cilia mostly from the perspective of vertebrate animal cells, with additional information from the wide range of ciliated eukaryotes where appropriate.
    [Show full text]
  • Overexpression of Motor Protein KIF17 Enhances Spatial and Working Memory in Transgenic Mice
    Overexpression of motor protein KIF17 enhances spatial and working memory in transgenic mice Richard Wing-Chuen Wong, Mitsutoshi Setou, Junlin Teng, Yosuke Takei, and Nobutaka Hirokawa* Department of Cell Biology and Anatomy, Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan Edited by Tomas Hokfelt, Karolinska Institute, Stockholm, Sweden, and approved September 11, 2002 (received for review June 28, 2002) The kinesin superfamily proteins (KIFs) play essential roles in where noted. Control WT mice were chosen from the same receptor transportation along the microtubules. KIF17 transports littermates. For the behavioral experiments, the same groups of the N-methyl-D-aspartate receptor NR2B subunit in vitro, but its male mice were used (10–12 wk). role in vivo is unknown. To clarify this role, we generated trans- genic mice overexpressing KIF17 tagged with GFP. The KIF17 Histological Analysis and Electron Microscopy. Mice (10–12 wk) were transgenic mice exhibited enhanced learning and memory in a anesthetized and fixed in FEA solution (5% formalin͞70% etha- series of behavioral tasks, up-regulated NR2B expression with the nol͞5% acetic acid). The brain tissues were then removed, washed, potential involvement of a transcriptional factor, the cAMP-depen- dehydrated in a graded series of ethanol, and embedded in Para- dent response element-binding protein, and increased phosphor- plast (Oxford Labware, St. Louis). The blocks were cut by using a ylation of the cAMP-dependent response element-binding protein. rotatory microtome (HM355; Rotary Microtome Zeiss) and sec- Our results suggest that the motor protein KIF17 contributes to tioned serially at 12-␮m thickness by using the same microtome.
    [Show full text]
  • Cytoskeletal Remodeling in Cancer
    biology Review Cytoskeletal Remodeling in Cancer Jaya Aseervatham Department of Ophthalmology, University of Texas Health Science Center at Houston, Houston, TX 77054, USA; Jaya.Aseervatham@uth.tmc.edu; Tel.: +146-9767-0166 Received: 15 October 2020; Accepted: 4 November 2020; Published: 7 November 2020 Simple Summary: Cell migration is an essential process from embryogenesis to cell death. This is tightly regulated by numerous proteins that help in proper functioning of the cell. In diseases like cancer, this process is deregulated and helps in the dissemination of tumor cells from the primary site to secondary sites initiating the process of metastasis. For metastasis to be efficient, cytoskeletal components like actin, myosin, and intermediate filaments and their associated proteins should co-ordinate in an orderly fashion leading to the formation of many cellular protrusions-like lamellipodia and filopodia and invadopodia. Knowledge of this process is the key to control metastasis of cancer cells that leads to death in 90% of the patients. The focus of this review is giving an overall understanding of these process, concentrating on the changes in protein association and regulation and how the tumor cells use it to their advantage. Since the expression of cytoskeletal proteins can be directly related to the degree of malignancy, knowledge about these proteins will provide powerful tools to improve both cancer prognosis and treatment. Abstract: Successful metastasis depends on cell invasion, migration, host immune escape, extravasation, and angiogenesis. The process of cell invasion and migration relies on the dynamic changes taking place in the cytoskeletal components; actin, tubulin and intermediate filaments. This is possible due to the plasticity of the cytoskeleton and coordinated action of all the three, is crucial for the process of metastasis from the primary site.
    [Show full text]
  • The Kinesin Superfamily Protein KIF17: One Protein with Many Functions
    BioMol Concepts, Vol. 3 (2012), pp. 267–282 • Copyright © by Walter de Gruyter • Berlin • Boston. DOI 10.1515/bmc-2011-0064 Review The kinesin superfamily protein KIF17: one protein with many functions Margaret T.T. Wong-Riley * and Joseph C. Besharse Introduction: kinesin superfamily proteins Department of Cell Biology , Neurobiology and Anatomy, Medical College of Wisconsin, 8701 Watertown Plank The kinesin superfamily proteins (KIFs) are microtubule- Road, Milwaukee, WI 53226 , USA based molecular motors that convert the chemical energy of adenosine triphosphate (ATP) hydrolysis to the mechani- * Corresponding author cal force of transporting cargos along microtubules. These e-mail: mwr@mcw.edu ATPases were fi rst identifi ed and partially purifi ed from squid giant axons and optic lobes, the bovine brain, the chick brain, Abstract and sea urchin eggs (1 – 3) . They form a high affi nity complex with microtubules in the presence of a non-hydrolyzable ATP Kinesins are ATP-dependent molecular motors that carry analog and their kinetic property prompted the term ‘ kine- cargos along microtubules, generally in an anterograde sin ’ (1) as the counterpart to the other microtubule-associated direction. They are classified into 14 distinct families with ATPase, dynein, described two decades earlier (4) . More than varying structural and functional characteristics. KIF17 is 98 % of all KIFs (611 out of 623 KIF proteins) have been clas- a member of the kinesin-2 family that is plus end-directed. sifi ed into 14 distinct families (kinesin-1 to -14) with many It is a homodimer with a pair of head motor domains that subfamily groupings (5, 6) .
    [Show full text]
  • 00196-2018 Supp Table
    Table S5: Compund heterozygous SNVs/Indels lung lung M SIFT lung MGI) gene gene Gene Patient Disease ISPP_AR samples tested samples tested ISPP_PAE database) databases) Variant type LUNG mouse CADD_phred Protein change Developmental Cancer (TCGA) frequency (in all Polyphen2_HDIV Gene description Cancer (COSMIC) in the Deciphering phenotype (mouse Nucleotide change in TCGA for a given #Gene inmutations in the Catalogue Of Percnetage of SNVs in the Catalogue Of (#mutations* TCGA Percnetage of SNVs (COSMIC database) and Indels in all genome informatics; and Indels in all Somatic Mutations In Somatic Mutations In Reference sequence in COSMIC for a given Phenotypes described Maximum minor allele ADC/MUC/BAAC/SCC cancer cancer Presence of the variant Presence of the variant name/Inheritance/OMI Disorders (DDD) project ADC/MUC*/BAAC/SCC Protein atlas/Literature search mRNA Expression in fetal lung (Roadmap)/Literature Reported in 1 lung ND missense c.1367G>A p.R456H 0.001029 D D 34.0 adenocarcinoma patient ND COSM335951 leucine zipper tumor Esophageal squamous cell LZTS1 YES NM_021020 Somatic in 1 small intestine, 26/0/0/2 1.14 ND 70/6/15/16 0.51 ND 0.08093 0.03918 suppressor 1 carcinoma/AD/133239 fibrous tissue and ND missense c.338T>C p.L113P 0.003086 D D 27.4 ND uncertain origin, CPAM2 COSM3734029 missense c.4537A>G p.K1513E 0.000580 D B 19.9 ND ND Deafness/AR/609533; Usher missense c.1959G>T p.E653D N T P 16.6 ND ND protocadherin related syndrome1D/F PCDH15 NO/YES NO/YES NM_001142769 Reported in 1 colon 203/0/0/52 9.43 ND 371/50/107/158
    [Show full text]
  • Membrane Proteins Take Different Trafficking Pathways to the Primary Cilium
    University of Massachusetts Medical School eScholarship@UMMS GSBS Dissertations and Theses Graduate School of Biomedical Sciences 2017-12-14 Membrane Proteins Take Different Trafficking Pathways to the Primary Cilium William Joseph Monis University of Massachusetts Medical School Let us know how access to this document benefits ou.y Follow this and additional works at: https://escholarship.umassmed.edu/gsbs_diss Part of the Cell Biology Commons, and the Developmental Biology Commons Repository Citation Monis WJ. (2017). Membrane Proteins Take Different Trafficking Pathways to the Primary Cilium. GSBS Dissertations and Theses. https://doi.org/10.13028/M2GX0S. Retrieved from https://escholarship.umassmed.edu/gsbs_diss/946 This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in GSBS Dissertations and Theses by an authorized administrator of eScholarship@UMMS. For more information, please contact Lisa.Palmer@umassmed.edu. MEMBRANE PROTEINS TAKE DIFFERENT TRAFFICKING PATHWAYS TO THE PRIMARY CILIUM A Dissertation Presented By William Joseph Monis Submitted to the Faculty of the University of Massachusetts Graduate School of Biomedical Sciences, Worcester in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY (DECEMBER, 14, 2017) INTERDISCIPLINARY GRADUATE PROGRAM MEMBRANE PROTEINS TAKE DIFFERENT TRAFFICKING PATHWAYS TO THE PRIMARY CILIUM A Dissertation Presented By William Joseph Monis This work was undertaken in the Graduate School of Biomedical Sciences Interdisciplinary Graduate Program The signature of the Thesis Advisor signifies validation of Dissertation content ⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯ Gregory J. Pazour, Ph.D., Thesis Advisor The signatures of the Dissertation Defense Committee signify completion and approval as to style and content of the Dissertation ⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯ Julie A.
    [Show full text]
  • Kif17 Phosphorylation Regulates Photoreceptor Outer Segment Turnover Tylor R
    Lewis et al. BMC Cell Biology (2018) 19:25 https://doi.org/10.1186/s12860-018-0177-9 RESEARCHARTICLE Open Access Kif17 phosphorylation regulates photoreceptor outer segment turnover Tylor R. Lewis1, Sean R. Kundinger2, Brian A. Link1, Christine Insinna1,3 and Joseph C. Besharse1,2* Abstract Background: KIF17, a kinesin-2 motor that functions in intraflagellar transport, can regulate the onset of photoreceptor outer segment development. However, the function of KIF17 in a mature photoreceptor remains unclear. Additionally, the ciliary localization of KIF17 is regulated by a C-terminal consensus sequence (KRKK) that is immediately adjacent to a conserved residue (mouse S1029/zebrafish S815) previously shown to be phosphorylated by CaMKII. Yet, whether this phosphorylation can regulate the localization, and thus function, of KIF17 in ciliary photoreceptors remains unknown. Results: Using transgenic expression in zebrafish photoreceptors, we show that phospho-mimetic KIF17 has enhanced localization along the cone outer segment. Importantly, expression of phospho-mimetic KIF17 is associated with greatly enhanced turnover of the photoreceptor outer segment through disc shedding in a cell- autonomous manner, while genetic mutants of kif17 in zebrafish and mice have diminished disc shedding. Lastly, cone expression of constitutively active tCaMKII leads to a kif17-dependent increase in disc shedding. Conclusions: Taken together, our data support a model in which phosphorylation of KIF17 promotes its photoreceptor outer segment localization and disc shedding, a process essential for photoreceptor maintenance and homeostasis. While disc shedding has been predominantly studied in the context of the mechanisms underlying phagocytosis of outer segments by the retinal pigment epithelium, this work implicates photoreceptor- derived signaling in the underlying mechanisms of disc shedding.
    [Show full text]
  • List of Antibodies Lot: 071M4826 Reactivity ANTIBODY SIGMA No
    Panorama® Antibody Microarray-XPRESS Profiler725, XP725 List of Antibodies Lot: 071M4826 Reactivity ANTIBODY SIGMA No. P/M Human Mouse Rat 1 14-3-3 θ/τ T5942 My y y 2 Acetylated Protein A5463 P y n/d n/d 3 Actin A5060 Pyy y 4 Actin A3853 My y y 5 Actin, α-Smooth Muscle A5228 My y y 6 β-Actin A1978 My y y 7 β-Actin A2228 My y y 8 α-Actinin A5044 My y n/d 9 Actopaxin A1226 P y n/d n/d 10 AP2 A7107 M y n/d n/d 11 β1 and β2-Adaptins A4450 M y n/d y 12 I-Afadin A0349 Pyy y 13 AFX A8975 P y n/d n/d 14 AFX (FOXO4) A5854 M y n/d n/d 15 AKR1C3 A6229 M y n/d n/d 16 Aly A9979 M y n/d n/d 17 β-Amyloid A8354 M y n/d n/d 18 Amyloid Precursor Protein, C-Terminal A8717 Pyy y 19 Amyloid Precursor Protein, N-Terminal A8967 Pyy y 20 Amyloid Precursor Protein, KPI Domain A8842 Pyy y 21 Androgen Receptor A9853 P y n/d y 22 Annexin V A8604 M y n/d n/d 23 Annexin VII A4475 M yy y 24 Anti Cy3+Cy5 C0992 M NA NA NA 25 AOP1AOP1 A7674A7674 M y y y 26 AP-1 A5968 P y n/d n/d 27 AP-2α A0844 P y n/d n/d 28 AP Endonuclease A2105 M yy y 29 Apaf1, N-Terminal A8469 P y y n/d 30 Apoptosis Inducing Factor (AIF) A7549 P y y n/d 31 APRIL, Extracellular Domain A1726 P y n/d n/d 32 APRIL, Extracellular Domain 2 A1851 P y n/d n/d 33 ARC, C-Terminal A8344 P y n/d n/d 34 ARNO (Cytohesin-2) A4721 M y n/d y 35 Arp1α/Centractin A5601 Pyy y 36 ARP2 A6104 M yy y 37 ARP3 A5979 M yy y 38 ARTS A3720 P y n/d n/d 39 ARTS A4471 M y n/d n/d 40 ASAP1/Centaurin β4 A4227 Pyy y 41 ASC-2 A5355 M y n/d n/d 42 ASPP1 A4355 M y y n/d 43 ASPP2 A4480 M y y n/d 44 ATF-1 A7833 P y n/d n/d 45 ATF2 A4086
    [Show full text]